{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:40:23Z","timestamp":1785253223743,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF-12345"],"award-info":[{"award-number":["KWF-12345"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF-12345"],"award-info":[{"award-number":["KWF-12345"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Netherlands Organization for Scientific Research Science XL","award":["2019.022"],"award-info":[{"award-number":["2019.022"]}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["Clinical Fellow 2023 09032212110047"],"award-info":[{"award-number":["Clinical Fellow 2023 09032212110047"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Hereditary diffuse gastric cancer (HDGC), caused by pathogenic variants (PVs) in\n                      <jats:italic>CDH1<\/jats:italic>\n                      , typically presents as early-stage mucosal lesions composed of non-proliferative signet ring cells (SRCs). While loss of E-cadherin initiates tumorigenesis, the somatic genetic alterations driving progression to advanced disease remain poorly understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Our goal was to identify morphological and genetic changes associated with HDGC progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We performed whole exome sequencing on 38 gastric tumors from 26 HDGC patients, spanning early to advanced stages, and compared genetic alterations across tumor stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Early-stage HDGC lesions exhibited minimal somatic alterations, with low tumor mutational burden (TMB) and few cancer-related mutations. In contrast, advanced tumors showed a significant increase in TMB and frequent somatic mutations in\n                      <jats:italic>CDH1<\/jats:italic>\n                      ,\n                      <jats:italic>TP53<\/jats:italic>\n                      , and genes involved in TGF-\u03b2 signaling, cell adhesion, and actomyosin contractility (e.g.,\n                      <jats:italic>SMAD4<\/jats:italic>\n                      ,\n                      <jats:italic>FAT4<\/jats:italic>\n                      ,\n                      <jats:italic>RHOA<\/jats:italic>\n                      ). Copy number variations (CNVs) were also more prevalent in advanced tumors, including recurrent loss of 3p and 17p and amplification of oncogenes\n                      <jats:italic>MYC<\/jats:italic>\n                      and\n                      <jats:italic>MET<\/jats:italic>\n                      . CNV profiles varied between tumor regions, indicating intratumoral heterogeneity and potential clonal evolution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      HDGC progression is marked by a stepwise accumulation of somatic mutations and chromosomal alterations. While early lesions remain genetically quiet, advanced tumors exhibit complex genetic landscapes, including\n                      <jats:italic>CDH1<\/jats:italic>\n                      inactivation, oncogenic mutations, and CNVs. These findings highlight key molecular events in HDGC progression and may inform future strategies for early detection and targeted intervention.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10120-026-01730-1","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:36:38Z","timestamp":1774596998000},"page":"527-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping the genetic landscape of hereditary diffuse-type gastric cancer progression"],"prefix":"10.1007","volume":"29","author":[{"given":"Lars J. S.","family":"Kemp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"van Cruchten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Lomans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk A. A.","family":"Brosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila L.","family":"Kodach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda M.","family":"van Dieren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Bisseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richarda","family":"de Voer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Gloerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7531-9599","authenticated-orcid":false,"given":"Chella R. S.","family":"van der Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"3","key":"1730_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"1730_CR2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1349-7006.2009.01163.x","volume":"100","author":"B Humar","year":"2009","unstructured":"Humar B, Guilford P. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci. 2009;100(7):1151\u20137.","journal-title":"Cancer Sci"},{"issue":"8","key":"1730_CR3","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","volume":"21","author":"VR Blair","year":"2020","unstructured":"Blair VR, McLeod M, Carneiro F, Coit DG, D\u2019Addario JL, van Dieren JM, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020;21(8):e386\u201397.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1730_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1470-2045(22)00643-X","volume":"24","author":"J Garcia-Pelaez","year":"2023","unstructured":"Garcia-Pelaez J, Barbosa-Matos R, Lobo S, Dias A, Garrido L, Castedo S, et al. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. Lancet Oncol. 2023;24(1):91\u2013106.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1730_CR5","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s10120-021-01191-8","volume":"24","author":"M Nikaido","year":"2021","unstructured":"Nikaido M, Kakiuchi N, Miyamoto S, Hirano T, Takeuchi Y, Funakoshi T, et al. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer. 2021;24(5):1102\u201314.","journal-title":"Gastric Cancer"},{"issue":"5","key":"1730_CR6","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1349-7006.2011.01890.x","volume":"102","author":"A Mimata","year":"2011","unstructured":"Mimata A, Fukamachi H, Eishi Y, Yuasa Y. Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci. 2011;102(5):942\u201350.","journal-title":"Cancer Sci"},{"issue":"6","key":"1730_CR7","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2015.10.003","volume":"28","author":"Y Hayakawa","year":"2015","unstructured":"Hayakawa Y, Ariyama H, Stancikova J, Sakitani K, Asfaha S, Renz BW, et al. Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche. Cancer Cell. 2015;28(6):800\u201314.","journal-title":"Cancer Cell"},{"issue":"3","key":"1730_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gutjnl-2011-300050","volume":"61","author":"S Shimada","year":"2012","unstructured":"Shimada S, Mimata A, Sekine M, Mogushi K, Akiyama Y, Fukamachi H, et al. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut. 2012;61(3):344\u201353.","journal-title":"Gut"},{"issue":"7","key":"1730_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jnci\/92.7.569","volume":"92","author":"G Tamura","year":"2000","unstructured":"Tamura G. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst. 2000;92(7):569\u201373.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1730_CR10","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1158\/0008-5472.CAN-08-2457","volume":"69","author":"B Humar","year":"2009","unstructured":"Humar B, Blair V, Charlton A, More H, Martin I, Guilford P. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res. 2009;69(5):2050\u20136.","journal-title":"Cancer Res"},{"issue":"7","key":"1730_CR11","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1053\/j.gastro.2009.02.065","volume":"136","author":"C Oliveira","year":"2009","unstructured":"Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carri\u00e7o R, Senz J, et al. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology. 2009;136(7):2137\u201348.","journal-title":"Gastroenterology"},{"issue":"3","key":"1730_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/path.2426","volume":"216","author":"M Barber","year":"2008","unstructured":"Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, et al. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008;216(3):295\u2013306.","journal-title":"J Pathol"},{"issue":"4","key":"1730_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/gutjnl-2020-320742","volume":"70","author":"H Nienh\u00fcser","year":"2021","unstructured":"Nienh\u00fcser H, Kim W, Malagola E, Ruan T, Valenti G, Middelhoff M, et al. Mist1+ gastric isthmus stem cells are regulated by Wnt5a and expand in response to injury and inflammation in mice. Gut. 2021;70(4):654\u201365.","journal-title":"Gut"},{"key":"1730_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-025-08708-6","volume":"640","author":"THH Coorens","year":"2025","unstructured":"Coorens THH, Collord G, Jung H, Wang Y, Moore L, Hooks Y, et al. The somatic mutation landscape of normal gastric epithelium. Nature. 2025;640:418.","journal-title":"Nature"},{"issue":"8","key":"1730_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13059-014-0428-9","volume":"15","author":"LD Nadauld","year":"2014","unstructured":"Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, et al. Metastatic tumor evolution and organoid modeling implicate TGFBR2as a cancer driver in diffuse gastric cancer. Genome Biol. 2014;15(8):428.","journal-title":"Genome Biol"},{"issue":"2","key":"1730_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2159-8290.CD-19-0811","volume":"10","author":"H Zhang","year":"2020","unstructured":"Zhang H, Schaefer A, Wang Y, Hodge RG, Blake DR, Diehl JN, et al. Gain-of-function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse gastric cancer. Cancer Discov. 2020;10(2):288\u2013305.","journal-title":"Cancer Discov"},{"issue":"12","key":"1730_CR17","doi-asserted-by":"publisher","first-page":"e2245836","DOI":"10.1001\/jamanetworkopen.2022.45836","volume":"5","author":"ZX Liu","year":"2022","unstructured":"Liu ZX, Zhang XL, Zhao Q, Chen Y, Sheng H, He CY, et al. Whole-exome sequencing among chinese patients with hereditary diffuse gastric cancer. JAMA Netw Open. 2022;5(12):e2245836.","journal-title":"JAMA Netw Open"},{"issue":"7517","key":"1730_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"8","key":"1730_CR19","doi-asserted-by":"publisher","first-page":"113064","DOI":"10.1016\/j.isci.2025.113064","volume":"28","author":"R Lomans","year":"2025","unstructured":"Lomans R, Angerilli V, Spronck J, Kodach LL, Gullo I, Carneiro F, et al. Deep learning for multiclass tumor cell detection in histopathology slides of hereditary diffuse gastric cancer. iScience. 2025;28(8):113064.","journal-title":"iScience"},{"issue":"1","key":"1730_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13029-016-0060-z","volume":"11","author":"M Riester","year":"2016","unstructured":"Riester M, Singh AP, Brannon AR, Yu K, Campbell CD, Chiang DY, et al. PureCN: copy number calling and SNV classification using targeted short read sequencing. Source Code Biol Med. 2016;11(1):13.","journal-title":"Source Code Biol Med"},{"key":"1730_CR21","doi-asserted-by":"crossref","unstructured":"Vasimuddin M, Misra S, Li H, Aluru S. Efficient architecture-aware acceleration of BWA-MEM for multicore systems. In: 2019 IEEE Int Parallel Distrib Process Symp. IEEE; 2019. p. 314\u201324.","DOI":"10.1109\/IPDPS.2019.00041"},{"key":"1730_CR22","doi-asserted-by":"crossref","unstructured":"Benjamin D, Sato T, Cibulskis K, Getz G, Stewart C, Lichtenstein L. Calling somatic SNVs and indels with Mutect2. bioRxiv. 2019. p. 861054.","DOI":"10.1101\/861054"},{"issue":"4","key":"1730_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1470-2045(23)00094-3","volume":"24","author":"RS van der Post","year":"2023","unstructured":"van der Post RS, Bisseling TM, van Dieren JM. Endoscopic surveillance: time for a paradigm shift in hereditary diffuse-type gastric cancer management? Lancet Oncol. 2023;24(4):311\u20132.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1730_CR24","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41467-018-03121-2","volume":"9","author":"S Ge","year":"2018","unstructured":"Ge S, Xia X, Ding C, Zhen B, Zhou Q, Feng J, et al. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018;9(1):1012.","journal-title":"Nat Commun"},{"issue":"16","key":"1730_CR25","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1158\/0008-5472.CAN-24-0169","volume":"84","author":"N Zhakula-Kostadinova","year":"2024","unstructured":"Zhakula-Kostadinova N, Taylor AM. Patterns of aneuploidy and signaling consequences in cancer. Cancer Res. 2024;84(16):2575\u201387.","journal-title":"Cancer Res"},{"issue":"23","key":"1730_CR26","doi-asserted-by":"publisher","first-page":"16961","DOI":"10.3390\/ijms242316961","volume":"24","author":"MV Nemtsova","year":"2023","unstructured":"Nemtsova MV, Kuznetsova EB, Bure IV. Chromosomal instability in gastric cancer: role in tumor development, progression, and therapy. Int J Mol Sci. 2023;24(23):16961.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1730_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/path.6000","volume":"258","author":"K Namikawa","year":"2022","unstructured":"Namikawa K, Tanaka N, Ota Y, Takamatsu M, Kosugi M, Tokai Y, et al. Genomic features of Helicobacter pylori -na\u00efve diffuse-type gastric cancer. J Pathol. 2022;258(3):300\u201311.","journal-title":"J Pathol"},{"issue":"1\u20132","key":"1730_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11010-010-0536-0","volume":"344","author":"L Zhang","year":"2010","unstructured":"Zhang L, Hou Y, Ashktorab H, Gao L, Xu Y, Wu K, et al. The impact of C-MYC gene expression on gastric cancer cell. Mol Cell Biochem. 2010;344(1\u20132):125\u201335.","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"1730_CR29","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/1541-7786.MCR-14-0192-T","volume":"12","author":"JW Park","year":"2014","unstructured":"Park JW, Jang SH, Park DM, Lim NJ, Deng C, Kim DY, et al. Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis. Mol Cancer Res. 2014;12(8):1088\u201399.","journal-title":"Mol Cancer Res"},{"key":"1730_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1541-7786.MCR-24-1039","volume":"23","author":"AF Gallanis","year":"2025","unstructured":"Gallanis AF, Gamble LA, Oguz C, Samaranayake SG, Kedei N, Hernandez MO, et al. Spatial analysis of hereditary diffuse gastric cancer reveals indolent phenotype of signet ring cell precursors. Mol Cancer Res. 2025;23:1\u201311.","journal-title":"Mol Cancer Res"},{"issue":"9","key":"1730_CR31","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1136\/gutjnl-2022-328332","volume":"72","author":"C Xu","year":"2023","unstructured":"Xu C, Huang KK, Law JH, Chua JS, Sheng T, Flores NM, et al. Comprehensive molecular phenotyping of ARID1A -deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities. Gut. 2023;72(9):1651\u201363.","journal-title":"Gut"},{"issue":"2","key":"1730_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1053\/j.gastro.2017.05.012","volume":"153","author":"SY Cho","year":"2017","unstructured":"Cho SY, Park JW, Liu Y, Park YS, Kim JJH, Yang H, et al. Sporadic early-onset diffuse gastric cancers have high frequency of somatic CDH1 alterations, but low frequency of somatic RHOA mutations compared with late-onset cancers. Gastroenterology. 2017;153(2):536-549.e26.","journal-title":"Gastroenterology"},{"issue":"6","key":"1730_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ng.2983","volume":"46","author":"K Wang","year":"2014","unstructured":"Wang K, Yuen ST, Xu J, Lee SP, Yan HHNN, Shi ST, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46(6):573\u201382.","journal-title":"Nat Genet"},{"issue":"5","key":"1730_CR34","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1172\/JCI134402","volume":"130","author":"J Li","year":"2020","unstructured":"Li J, Wang W, Zhang Y, Cie\u015blik M, Guo J, Tan M, et al. Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy. J Clin Investig. 2020;130(5):2712\u201326.","journal-title":"J Clin Investig"},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gutjnl-2024-334589","volume":"74","author":"LJS Kemp","year":"2025","unstructured":"Kemp LJS, Monster JL, Wood CS, Moers M, Vliem MJ, Khalil AA, et al. Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression. Gut. 2025;74:1\u201311.","journal-title":"Gut"},{"issue":"7891","key":"1730_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41586-021-04217-4","volume":"601","author":"T Zhao","year":"2022","unstructured":"Zhao T, Chiang ZD, Morriss JW, LaFave LM, Murray EM, Del Priore I, et al. Spatial genomics enables multi-modal study of clonal heterogeneity in tissues. Nature. 2022;601(7891):85\u201391.","journal-title":"Nature"},{"issue":"7845","key":"1730_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41586-020-03126-2","volume":"590","author":"Y Takei","year":"2021","unstructured":"Takei Y, Yun J, Zheng S, Ollikainen N, Pierson N, White J, et al. Integrated spatial genomics reveals global architecture of single nuclei. Nature. 2021;590(7845):344\u201350.","journal-title":"Nature"},{"issue":"7","key":"1730_CR38","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mc.22803","volume":"57","author":"JW Park","year":"2018","unstructured":"Park JW, Kim MS, Voon DC, Kim SJ, Bae J, Mun DG, et al. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice. Mol Carcinog. 2018;57(7):947\u201354.","journal-title":"Mol Carcinog"},{"issue":"4","key":"1730_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.devcel.2018.09.016","volume":"47","author":"BR Acharya","year":"2018","unstructured":"Acharya BR, Nestor-Bergmann A, Liang X, Gupta S, Duszyc K, Gauquelin E, et al. A mechanosensitive RhoA pathway that protects epithelia against acute tensile stress. Dev Cell. 2018;47(4):439-452.e6.","journal-title":"Dev Cell"},{"issue":"1","key":"1730_CR40","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1038\/s41467-019-11716-6","volume":"10","author":"K Schipper","year":"2019","unstructured":"Schipper K, Seinstra D, Paulien Drenth A, van der Burg E, Ramovs V, Sonnenberg A, et al. Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin. Nat Commun. 2019;10(1):3800.","journal-title":"Nat Commun"},{"issue":"1","key":"1730_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-30294-8","volume":"13","author":"B Holm","year":"2023","unstructured":"Holm B, Barsuhn S, Behrens HM, Kr\u00fcger S, R\u00f6cken C. The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependent. Sci Rep. 2023;13(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"4","key":"1730_CR42","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cell.2018.07.027","volume":"174","author":"K Nanki","year":"2018","unstructured":"Nanki K, Toshimitsu K, Takano A, Fujii M, Shimokawa M, Ohta Y, et al. Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis. Cell. 2018;174(4):856-869.e17.","journal-title":"Cell"},{"issue":"6","key":"1730_CR43","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/jcb.22219","volume":"107","author":"AY Hui","year":"2009","unstructured":"Hui AY, Meens JA, Schick C, Organ SL, Qiao H, Tremblay EA, et al. Src and FAK mediate cell-matrix adhesion-dependent activation of MET during transformation of breast epithelial cells. J Cell Biochem. 2009;107(6):1168\u201381.","journal-title":"J Cell Biochem"},{"issue":"20","key":"1730_CR44","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1200\/JCO.2024.42.16_suppl.3515","volume":"8","author":"M Sharma","year":"2024","unstructured":"Sharma M, Strickler JH, Sommerhalder D, Kuboki Y, Perets R, Cohen J, et al. First-in-human study of ABBV-400, a novel c-Met\u2014targeting antibody-drug conjugate, in advanced solid tumors: results in colorectal cancer. J Clin Oncol. 2024;8(20):3515.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1730_CR45","first-page":"5031","volume":"32","author":"JS Choi","year":"2012","unstructured":"Choi JS, Seo J, Jung EJ, Kim EJ, Lee GK, Kim WH. c-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors. Anticancer Res. 2012;32(11):5031\u20138.","journal-title":"Anticancer Res"},{"issue":"2","key":"1730_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/ircmj.21221","volume":"18","author":"M Khaleghian","year":"2016","unstructured":"Khaleghian M, Jahanzad I, Shakoori A, Razavi AE, Azimi C. Association between amplification and expression of C-MYC gene and clinicopathological characteristics of stomach cancer. Iran Red Crescent Med J. 2016;18(2):1\u201310.","journal-title":"Iran Red Crescent Med J"},{"issue":"12","key":"1730_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines11123172","volume":"11","author":"S Byeon","year":"2023","unstructured":"Byeon S, Jung J, Kim ST, Kim KM, Lee J. Clinical implication of concurrent amplification of MET and FGFR2 in metastatic gastric cancer. Biomedicines. 2023;11(12):1\u201311.","journal-title":"Biomedicines"},{"issue":"4","key":"1730_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):1\u201314.","journal-title":"Genome Biol"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-026-01730-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:58:50Z","timestamp":1781643530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-026-01730-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1007\/s10120-026-01730-1","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}